E75.24 Niemann-Pick disease

Name of the Condition

• Niemann-Pick disease (ICD-10 Code: E75.24)

Summary

Niemann-Pick disease is a rare inherited lysosomal storage disorder characterized by the abnormal accumulation of lipids, particularly sphingomyelin, in cells. This buildup disrupts normal cellular function, affecting organs such as the liver, spleen, and nervous system. The condition is part of a broader group of sphingolipid metabolism disorders and presents with variable clinical manifestations depending on the subtype.

Causes

These disorders result from genetic mutations that impair the activity of enzymes or proteins involved in lipid breakdown. The mutations lead to the buildup of specific lipids in tissues. Inheritance is typically autosomal recessive, meaning both copies of the gene must be mutated for the condition to manifest.

Risk Factors

• Family history of Niemann-Pick disease or related lysosomal storage disorders.
• Consanguineous relationships, increasing the likelihood of recessive gene mutations.
• Ethnic backgrounds with higher carrier frequencies for specific subtypes.

Symptoms

• Enlarged liver and spleen (hepatosplenomegaly).
• Progressive neurological decline, including developmental delay or regression.
• Muscle weakness, hypotonia, or spasticity.
• Seizures or abnormal eye movements.
• Loss of motor skills or speech.
• Respiratory difficulties in severe cases.

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests to measure lipid levels or enzyme activity, and genetic testing to identify mutations. Imaging studies may assess organ enlargement or neurological changes. Biopsy of affected tissues (e.g., bone marrow) can confirm lipid accumulation.

Treatment Options

Treatment focuses on managing symptoms and complications. This may include enzyme replacement therapy (for some subtypes), substrate reduction therapy, or bone marrow transplantation. Supportive care addresses neurological, respiratory, or organ-specific issues. No cure exists, but interventions aim to improve quality of life.

Prognosis and Follow-Up

Prognosis varies by subtype, with some forms progressing rapidly and others more slowly. Regular monitoring of organ function, neurological status, and growth is essential. Follow-up care often involves a multidisciplinary team to address evolving symptoms and complications.

Complications

• Severe neurological impairment or loss of motor function.
• Respiratory failure due to muscle weakness.
• Liver or spleen dysfunction.
• Developmental delays or regression.
• Increased risk of infections.

Lifestyle & Prevention

While prevention of the genetic condition is not possible, supportive lifestyle measures may help manage symptoms. This includes physical therapy to maintain mobility, nutritional support, and adaptive equipment for daily activities. Genetic counseling is recommended for families with a history of the disorder.

When to Seek Professional Help

Seek medical attention if symptoms such as unexplained organ enlargement, neurological changes (e.g., loss of skills), or respiratory difficulties develop. Early evaluation is critical for diagnosis and management, especially in children showing developmental delays.

Tips for Medical Coders

Document the specific subtype of Niemann-Pick disease (e.g., type A, B, or C) when available, as this may impact coding and clinical context. Ensure documentation supports the diagnosis, including clinical findings, genetic testing results, or biopsy reports. Code E75.24 is specific to Niemann-Pick disease; verify that the clinical presentation aligns with this condition to avoid miscoding.